Core Insights - Procter & Gamble Company (PG) reported strong first-quarter fiscal 2026 results, with sales and earnings per share (EPS) exceeding estimates and showing year-over-year improvement [1][2] - The company's core EPS increased by 3% to $1.99, surpassing the Zacks Consensus Estimate of $1.90 [1][7] - Net sales reached $22.4 billion, reflecting a 3% year-over-year growth and exceeding the Zacks Consensus Estimate of $22.2 billion [2][7] Sales Performance - Organic sales rose by 2% year over year, driven by a 1% increase from pricing and a favorable product mix, while organic volume had a neutral impact [2][4] - Sales growth was led by a 6% increase in the Beauty segment, 5% in Grooming, 2% in Health Care, and 1% each in Baby, Feminine & Family Care and Fabric & Home Care [4][7] Margin Analysis - The core gross margin declined by 50 basis points to 51.5%, while the reported gross margin fell by 70 basis points [7][8] - Core selling, general and administrative expenses (SG&A) as a percentage of sales decreased by 40 basis points to 24.9% [9] - The core operating margin remained flat at 26.7%, with a currency-neutral increase of 40 basis points to 27.1% [10] Financial Position - Procter & Gamble ended the quarter with cash and cash equivalents of $11.2 billion and long-term debt of $24.3 billion [12] - The company generated an operating cash flow of $5.4 billion and an adjusted free cash flow of $4.9 billion, achieving a productivity rate of 102% [12][13] Shareholder Returns - In the first quarter, Procter & Gamble returned $3.8 billion to shareholders, including $2.55 billion in dividends and $1.25 billion in share buybacks [13] Fiscal 2026 Guidance - The company anticipates all-in sales growth of 1-5% for fiscal 2026, with organic sales expected to be flat to up 4% [14][15] - Core EPS is projected to grow by 3-9% compared to fiscal 2025, with a core EPS range of $6.83-$7.09 [15] - Procter & Gamble expects capital expenditure to be 4-5% of net sales and plans to pay out $10 billion in dividends and repurchase $5 billion in shares during fiscal 2026 [17]

Q1 FY 2026 Performance - Organic sales grew by 2% driven by pricing and mix[13] - Organic volume growth was flat at 0%[15] - Core earnings per share (EPS) increased by 3% to $1.99[14] - Currency-neutral core EPS also grew by 3%[14] - Adjusted free cash flow productivity was 102%[15] Segment Results - Beauty segment organic sales increased by 6% with volume up 4%[34] - Grooming segment organic sales grew by 3% with volume up 1%[37] - Health Care segment organic sales increased by 1% with volume down 2%[40] - Fabric & Home Care segment organic sales was flat at 0% with volume down 2%[43] - Baby, Feminine and Family Care segment organic sales and volume were flat at 0%[46] FY 2026 Guidance - Organic sales growth is projected to be between 0% and +4%[51] - Net sales growth is expected to be between +1% and +5%, including a 1% positive impact from foreign exchange and acquisitions/divestitures[51] - Core EPS growth is guided to be between +0% and +4%[53] - All-in EPS growth is projected to be between +3% and +9%[54] - The company anticipates ~$10 billion in dividends and ~$5 billion in direct share repurchases[57]

Group 1 - The Procter & Gamble Company (NYSE:PG) is recognized as one of the 11 Most Profitable Blue Chip Stocks to consider for investment [1] - Wells Fargo has revised its price target for Procter & Gamble from $173 to $170, reflecting a 1.73% decrease, while maintaining an Overweight rating [2] - Analysts show consistent confidence in Procter & Gamble's long-term growth, with BNP Paribas reiterating an Outperform rating at $177 and UBS lowering its target to $180 [2] Group 2 - Procter & Gamble has a diverse portfolio across various categories, generating approximately $85 billion in annual sales, with over 20 brands each exceeding $1 billion in international sales [3] - The company's stock stability is attributed to a balanced mix of high-growth and mature product areas, alongside ongoing global demand for consumer necessities [3][4] - Procter & Gamble offers branded consumer packaged goods in sectors such as Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care [4]

Core Insights - Procter & Gamble (PG) reported revenue of $20.89 billion for the quarter ended June 2025, marking a year-over-year increase of 1.7% and exceeding the Zacks Consensus Estimate by 0.39% [1] - The earnings per share (EPS) for the same period was $1.48, up from $1.40 a year ago, representing a surprise of 3.5% over the consensus estimate of $1.43 [1] Financial Performance Metrics - Organic Sales Growth for Beauty was 1%, below the average estimate of 1.7% [4] - Organic Sales Growth for Grooming was 1%, compared to the estimated 2.8% [4] - Total Organic Sales Growth for P&G was 2%, exceeding the average estimate of 1.4% [4] - Organic Sales Growth for Baby, Feminine & Family Care was 1%, above the estimate of 0.6% [4] - Organic Sales Growth for Fabric & Home Care was 1%, slightly below the estimate of 1.4% [4] - Organic Sales Growth for Health Care was 2%, below the average estimate of 3.1% [4] Net Sales Performance - Net sales for Beauty were $3.73 billion, slightly below the estimate of $3.76 billion, with a year-over-year change of +0.2% [4] - Net sales for Grooming were $1.68 billion, matching the average estimate, with a year-over-year increase of +1.6% [4] - Net sales for Corporate were $274 million, significantly above the estimate of $186.14 million, representing a +35.6% change year-over-year [4] - Net sales for Fabric & Home Care were $7.39 billion, slightly above the estimate of $7.36 billion, with a year-over-year change of +1.7% [4] - Net sales for Baby, Feminine & Family Care were $5.09 billion, exceeding the estimate of $5.02 billion, with a year-over-year change of +1.7% [4] - Net sales for Health Care were $2.72 billion, slightly below the estimate of $2.74 billion, with a year-over-year change of +1.8% [4] Stock Performance - P&G shares have returned -1.4% over the past month, while the Zacks S&P 500 composite has increased by +3.6% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Financial Performance - FY2025 - Organic sales grew by 2% driven by volume and pricing[7] - Core earnings per share (EPS) increased by 4% to $6.83 compared to the prior year[8] - Currency neutral core EPS also increased by 4%[8] - Adjusted free cash flow productivity was 87%[9] Financial Performance - Q4 FY2025 - Organic sales grew by 2%[26] - Core EPS grew by 6%[26] - Currency neutral core EPS grew by 5%[26] - Adjusted free cash flow productivity was 110%[26] Shareholder Returns - The company returned $9.9 billion to shareholders via dividends and share repurchases in FY2025[23] - Total cash returned to owners over the past 10 years amounts to $151 billion[23] - Share repurchase amounted to $6.5 billion in FY2025[23] FY2026 Guidance - The company projects organic sales growth of +0% to +4%[55] - Net sales growth is projected to be +1% to +5%, including a 1% positive impact from foreign exchange and acquisitions/divestitures[55] - Core EPS growth is guided at +0% to +4%[57] - The company anticipates paying approximately $10 billion in dividends and repurchasing approximately $5 billion in shares[60]

Company Overview - Ontex Group NV is a leading international developer and producer of baby, feminine, and adult care products, serving both retailers and the healthcare sector [3] - The company distributes its innovative products in around 100 countries and employs approximately 7,000 people across 14 countries, with its headquarters located in Aalst, Belgium [3] - Ontex is listed on Euronext Brussel and is a constituent of the Bel Mid index [3] Financial Update - Ontex has announced an unconditional notice of redemption for its 3.500% Senior Notes due 2026, notifying holders that it will redeem all remaining outstanding Notes, along with accrued and unpaid interest, on July 15, 2025 [1] - Following a cash tender offer launched in March and concluded in April 2026, Ontex accepted €283,095,000 out of the originally issued €580,000,000, leaving a remaining outstanding amount of €296,905,000 [1]

Core Viewpoint - The recent sell-off in Procter & Gamble (P&G) stock presents a buying opportunity for investors seeking reliable passive income, despite the company's mediocre growth in recent years [2][10]. Group 1: Competitive Advantages - P&G possesses a strong portfolio of well-known brands across various categories, leading to high margins and sustained growth, with international sales exceeding domestic sales [4]. - The company effectively leverages its global supply chain and marketing, benefiting from diversification and avoiding over-reliance on a few brands [5]. - P&G focuses on expanding its existing brand lineup rather than pursuing large acquisitions, with its last major acquisition being Gillette for $57 billion two decades ago [6]. Group 2: Financial Performance and Dividends - P&G has consistently increased its dividend for 69 consecutive years, supported by steady growth in margins and free cash flow (FCF) per share, despite a current yield of 2.6% [10]. - The company generates significantly more FCF than needed for dividends, allowing for consistent stock buybacks, which have reduced the share count by 5.5% over the last five years and 13.6% over the last decade [12]. - P&G's earnings growth is driven by sales volume growth, price increases, operating margin expansion, and stock buybacks [12]. Group 3: Valuation and Investment Suitability - P&G commands a premium valuation due to its industry leadership and steady earnings, with a price-to-earnings (P/E) ratio of 26.3, which may appear high but is justified upon closer examination [13]. - The company's P/E and price-to-FCF ratios are around five-year median levels, suggesting potential for the stock to appear undervalued if earnings continue to rise [15]. - P&G is considered a foundational holding for risk-averse investors, particularly during economic downturns and geopolitical uncertainty, despite the presence of cheaper stocks with higher yields [16][17].

Group 1 - RH is under investigation for potential violations of federal securities laws, as announced by Bleichmar Fonti & Auld LLP [1] - RH operates primarily in the home furnishings market, offering a variety of products including furniture, lighting, textiles, and outdoor furnishings [2] - Despite claims of accelerated demand, RH was actually facing softening demand and macroeconomic challenges that necessitated delays in new collections [3] Group 2 - On April 2, 2025, RH reported disappointing earnings for FY 2024, citing softening demand and excess inventory estimated between $200 million to $300 million [4] - Following the earnings report, RH's stock price plummeted by 40%, dropping from $249.35 to $149.39 per share within a day [4]

Group 1: Investigation Overview - Bleichmar Fonti & Auld LLP is investigating RH for potential violations of federal securities laws [1] - RH is a luxury lifestyle brand primarily in the home furnishings market, offering a variety of products including furniture and décor [2] Group 2: Company Performance and Market Conditions - During the relevant period, RH claimed accelerated demand despite challenging housing market conditions and indicated a higher level of inventory for downside protection [3] - However, RH was actually experiencing softening demand and macroeconomic challenges that necessitated delays in new collections [3] Group 3: Stock Market Reaction - On April 2, 2025, RH reported disappointing earnings for FY 2024, citing softening demand, an uncertain macroeconomic environment, and excess inventory valued at $200 to $300 million [4] - Following this announcement, RH's stock price plummeted by 40%, dropping from $249.35 per share to $149.39 per share within a day [4]

Core Viewpoint - RH is under investigation for potential violations of federal securities laws, following a significant decline in stock price after disappointing earnings reports and revelations about softening demand and excess inventory [1][4]. Company Overview - RH operates as a retailer and luxury lifestyle brand primarily in the home furnishings market, offering a variety of products including furniture, lighting, textiles, and outdoor furnishings [2]. Recent Developments - During a challenging housing market, RH claimed to experience accelerated demand and planned to introduce new collections, but was actually facing softening demand and macroeconomic challenges that necessitated delays in product launches [3]. - On April 2, 2025, RH reported disappointing earnings for FY 2024, citing softening demand, an uncertain macroeconomic environment, and excess inventory valued between $200 million and $300 million [4]. Stock Performance - Following the earnings report, RH's stock price plummeted by 40%, dropping from $249.35 per share on April 2, 2025, to $149.39 per share on April 3, 2025, reflecting investor reaction to the negative news [4].